MCID: EXC002
MIFTS: 43

Exocrine Pancreatic Insufficiency malady

Categories: Endocrine diseases

Aliases & Classifications for Exocrine Pancreatic Insufficiency

Aliases & Descriptions for Exocrine Pancreatic Insufficiency:

Name: Exocrine Pancreatic Insufficiency 38 12 29 52 42 14 69

Classifications:



External Ids:

Disease Ontology 12 DOID:13316
MeSH 42 D010188
NCIt 47 C84316
SNOMED-CT 64 47367009
UMLS 69 C0267963

Summaries for Exocrine Pancreatic Insufficiency

MalaCards based summary : Exocrine Pancreatic Insufficiency is related to netherton syndrome and exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis. An important gene associated with Exocrine Pancreatic Insufficiency is SCT (Secretin), and among its related pathways/superpathways are Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers and Pancreatic secretion. The drugs Pancrelipase and Nitazoxanide have been mentioned in the context of this disorder. Affiliated tissues include Pancreas, pancreas and testes, and related phenotypes are digestive/alimentary and endocrine/exocrine gland

Wikipedia : 71 Exocrine pancreatic insufficiency (EPI) is the inability to properly digest food due to a lack of... more...

Related Diseases for Exocrine Pancreatic Insufficiency

Diseases related to Exocrine Pancreatic Insufficiency via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 67)
id Related Disease Score Top Affiliating Genes
1 netherton syndrome 29.2 CCK CFTR PNLIP SCT
2 exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis 12.5
3 shwachman-diamond syndrome 11.6
4 johanson-blizzard syndrome 11.4
5 pancreatic agenesis 2 11.0
6 pancreatic agenesis 1 11.0
7 pancreatitis 11.0
8 cystic fibrosis 10.5
9 gastrointestinal neuroendocrine benign tumor 10.2 CCK SCT
10 tricuspid valve insufficiency 10.2 CCK SCT
11 bazex syndrome 10.2 CCK SCT
12 tricuspid valve stenosis 10.2 CCK SCT
13 breast malignant eccrine spiradenoma 10.2 CCK SCT
14 adult brain stem glioma 10.2 CCK SCT
15 gemistocytic astrocytoma 10.2 CCK SCT
16 primrose syndrome 10.1 CCK SCT
17 acute contagious conjunctivitis 10.1 CCK CCKAR
18 myxofibrosarcoma 10.1 CFTR SCT
19 primary pigmented nodular adrenocortical disease 10.1 CCK CCKAR
20 duodenitis 10.1
21 steatorrhea 10.1
22 cervical adenomyoma 10.1 CCK CFTR
23 pulmonary venoocclusive disease 2 10.1 CFTR UBR1
24 tuberculous peritonitis 10.1 CCK CCKAR
25 mandibular cancer 10.1 CCK CCKAR
26 retinal vascular occlusion 10.1 CCK SCT
27 focal segmental glomerulosclerosis 8 10.1 PDX1 PTF1A
28 borderline leprosy 10.0 CCK CCKAR
29 chondroma 10.0 CCK SCT
30 childhood malignant hemangiopericytoma 10.0 CCK CCKAR SCT
31 distal muscular dystrophy 10.0 PDX1 PTF1A
32 neutropenia 9.9
33 somatostatinoma 9.9
34 celiac disease 9.9
35 neurofibromatosis 9.9
36 dwarfism 9.9
37 ichthyosis 9.9
38 dysostosis 9.9
39 non-syndromic intellectual disability 9.9 CFTR PDX1 PTF1A
40 acute gonococcal cervicitis 9.9 CCK PNLIP SCT
41 autoimmune hepatitis 9.8
42 gastritis 9.8
43 diabetic neuropathy 9.8
44 hepatitis 9.8
45 thyroiditis 9.8
46 liver disease 9.8
47 duodenal somatostatinoma 9.8
48 obesity 9.8
49 neuropathy 9.8
50 tropical sprue 9.8

Graphical network of the top 20 diseases related to Exocrine Pancreatic Insufficiency:



Diseases related to Exocrine Pancreatic Insufficiency

Symptoms & Phenotypes for Exocrine Pancreatic Insufficiency

MGI Mouse Phenotypes related to Exocrine Pancreatic Insufficiency:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.8 CCKAR CFTR PDX1 PNLIP PTF1A UBR1
2 endocrine/exocrine gland MP:0005379 9.73 CCK CCKAR CFTR PDX1 PTF1A UBR1
3 growth/size/body region MP:0005378 9.7 CCKAR CFTR COX4I2 PDX1 PNLIP PTF1A
4 homeostasis/metabolism MP:0005376 9.56 CCK CCKAR CFTR COX4I2 PDX1 PNLIP
5 liver/biliary system MP:0005370 9.02 PDX1 PNLIP PTF1A CCKAR CFTR

Drugs & Therapeutics for Exocrine Pancreatic Insufficiency

Drugs for Exocrine Pancreatic Insufficiency (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 118)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Pancrelipase Approved Phase 4,Phase 2,Phase 3,Phase 1 53608-75-6
2
Nitazoxanide Approved, Investigational, Vet_approved Phase 4 55981-09-4 41684
3 Gastrointestinal Agents Phase 4,Phase 2,Phase 3,Phase 1
4 pancreatin Phase 4,Phase 2,Phase 3,Phase 1
5 Anti-Infective Agents Phase 4,Phase 2,Phase 3
6 Antiparasitic Agents Phase 4
7 Bifidobacterium Nutraceutical Phase 4
8
Omeprazole Approved, Investigational, Vet_approved Phase 3 73590-58-6 4594
9
Busulfan Approved, Investigational Phase 2, Phase 3 55-98-1 2478
10
Fludarabine Approved Phase 2, Phase 3 21679-14-1, 75607-67-9 30751
11
Vidarabine Approved Phase 2, Phase 3 24356-66-9 32326 21704
12
alemtuzumab Approved, Investigational Phase 2, Phase 3 216503-57-0
13
Cyclophosphamide Approved, Investigational Phase 2, Phase 3 50-18-0, 6055-19-2 2907
14
Lenograstim Approved Phase 2, Phase 3 135968-09-1
15 Pharmaceutical Solutions Phase 3,Phase 1,Phase 2
16 Antacids Phase 3
17 Anti-Ulcer Agents Phase 3
18
Proton pump inhibitors Phase 3
19 Alkylating Agents Phase 2, Phase 3
20 Antilymphocyte Serum Phase 2, Phase 3
21 Antimetabolites Phase 2, Phase 3
22 Antimetabolites, Antineoplastic Phase 2, Phase 3
23 Antineoplastic Agents, Alkylating Phase 2, Phase 3
24 Antiviral Agents Phase 2, Phase 3
25 Immunosuppressive Agents Phase 2, Phase 3, Phase 1
26 Antirheumatic Agents Phase 2, Phase 3,Phase 1
27 Adjuvants, Immunologic Phase 2, Phase 3
28
Secretin Approved, Investigational Phase 2 108153-74-8
29
Benzocaine Approved Phase 2 1994-09-7, 94-09-7 2337
30
Selenium Approved, Vet_approved Phase 2 7782-49-2
31
Zinc Approved Phase 2 7440-66-6 32051 23994
32
Cefazolin Approved Phase 2 25953-19-9 656510 33255
33
Dalteparin Approved Phase 2 9041-08-1
34
Heparin Approved, Investigational Phase 2 9005-49-6 772 46507594
35
Metoclopramide Approved, Investigational Phase 2 364-62-5 4168
36
Octreotide Approved, Investigational Phase 2 83150-76-9 383414 6400441
37
Melphalan Approved Phase 2 148-82-3 4053 460612
38
Mycophenolate mofetil Approved, Investigational Phase 2,Phase 1 128794-94-5 5281078
39
Mycophenolic acid Approved Phase 2,Phase 1 24280-93-1 446541
40
Mechlorethamine Approved Phase 2 51-75-2 4033
41
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
42
Tacrolimus Approved, Investigational Phase 2 104987-11-3 445643 439492
43
Choline Approved, Nutraceutical Phase 2 62-49-7 305
44 tannic acid Approved, Nutraceutical Phase 2
45
Vitamin A Approved, Nutraceutical, Vet_approved Phase 2 11103-57-4, 68-26-8 445354
46
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
47
leucovorin Approved, Nutraceutical Phase 2 58-05-9 54575, 6560146 143
48 Bile Acids and Salts Phase 2
49 Hypolipidemic Agents Phase 2
50 Lipid Regulating Agents Phase 2

Interventional clinical trials:

(show top 50) (show all 100)
id Name Status NCT ID Phase
1 Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency Completed NCT01327703 Phase 4
2 PR-018: An Open-Label, Safety Extension of Study PR-011 Completed NCT01131507 Phase 4
3 A Study to Evaluate the Mode of Administration and Safety of EUR-1008 (APT-1008) in Infants 1 to 12 Months of Age Completed NCT01100606 Phase 4
4 Creon After Pancreatic Surgery Completed NCT00535756 Phase 4
5 Enzyme Suppletion in Exocrine Pancreatic Dysfunction Completed NCT01430234 Phase 4
6 Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea Completed NCT00572975 Phase 4
7 Evaluation of the Digestive and Metabolic Utilisation of Dietary Protein in Patients With Chronic Pancreatitis Completed NCT00957151 Phase 4
8 Irritable Bowel Syndrome Evaluation and Treatment in Primary Care Completed NCT01641341 Phase 4
9 EASY: Extended Access to Sollpura Over Years Recruiting NCT02823964 Phase 4
10 Creon Use in Coeliac Patients With Low Faecal Pancreatic Elastase Terminated NCT01865695 Phase 4
11 Intraduodenal Aspiration Study to Assess the Bioavailability of Oral Pancrecarb® Compared to Placebo Control Terminated NCT00744250 Phase 4
12 A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2 Withdrawn NCT02009410 Phase 4
13 Pancreatic Enzyme Suppletion in Pancreatic Cancer Withdrawn NCT01401387 Phase 4
14 Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic Insufficiency Unknown status NCT01012908 Phase 2, Phase 3
15 Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis. Completed NCT01641393 Phase 3
16 Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency Completed NCT00449878 Phase 3
17 Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency Completed NCT00981214 Phase 3
18 Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency Completed NCT00297167 Phase 3
19 A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency Completed NCT00662675 Phase 3
20 A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI) Completed NCT00788593 Phase 3
21 A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency Completed NCT00400842 Phase 3
22 Open-Label Phase III Long-Term Safety Trial of Liprotamase Completed NCT00449904 Phase 3
23 Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI) Completed NCT00408317 Phase 3
24 A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy Completed NCT00414908 Phase 3
25 Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Completed NCT00775528 Phase 3
26 Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF) Completed NCT00690820 Phase 3
27 SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis Completed NCT02734810 Phase 3
28 A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Pancreatic Exocrine Insufficiency Completed NCT00401076 Phase 3
29 Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than Four Years With Pancreatic Exocrine Insufficiency Completed NCT01747330 Phase 3
30 Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis Completed NCT00705978 Phase 3
31 SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis Completed NCT02279498 Phase 3
32 Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis Completed NCT00510484 Phase 3
33 Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea Completed NCT00559364 Phase 3
34 A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Completed NCT02137382 Phase 3
35 Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI) Completed NCT00513682 Phase 3
36 Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis Completed NCT00432861 Phase 3
37 Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF) Completed NCT00880100 Phase 3
38 Stem Cell Transplant for Bone Marrow Failure Syndromes Completed NCT00176878 Phase 2, Phase 3
39 RESULT: Reliable, Emergent Solution Using Liprotamase Treatment Recruiting NCT03051490 Phase 3
40 Stem Cell Transplant for Hemoglobinopathy Active, not recruiting NCT00176852 Phase 2, Phase 3
41 Phase III ALTU-135 CP Safety Trial Terminated NCT00500084 Phase 3
42 Effectiveness of Pancreatic Enzymes in Patients Pancreatic Insufficient: Comparison of Two Drugs Withdrawn NCT01228643 Phase 3
43 Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis Completed NCT01710644 Phase 1, Phase 2
44 Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Completed NCT02415959 Phase 2
45 Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency Completed NCT00095732 Phase 2
46 An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI) Completed NCT00559052 Phase 2
47 Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency Completed NCT00743483 Phase 2
48 A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI Completed NCT02370537 Phase 2
49 BreathID® Test: A Non-invasive Modality to Detect Pancreatic Exocrine Insufficiency Completed NCT01259544 Phase 2
50 Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI Completed NCT00406536 Phase 2

Search NIH Clinical Center for Exocrine Pancreatic Insufficiency

Cochrane evidence based reviews: exocrine pancreatic insufficiency

Genetic Tests for Exocrine Pancreatic Insufficiency

Genetic tests related to Exocrine Pancreatic Insufficiency:

id Genetic test Affiliating Genes
1 Exocrine Pancreatic Insufficiency 29

Anatomical Context for Exocrine Pancreatic Insufficiency

MalaCards organs/tissues related to Exocrine Pancreatic Insufficiency:

39
Pancreas, Testes, Small Intestine, Neutrophil, Liver, Skin, Salivary Gland
LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Exocrine Pancreatic Insufficiency:
id Tissue Anatomical CompartmentCell Relevance
1 Pancreas Pancreatic Acini Acinar Cells Potential therapeutic candidate, affected by disease

Publications for Exocrine Pancreatic Insufficiency

Articles related to Exocrine Pancreatic Insufficiency:

(show top 50) (show all 256)
id Title Authors Year
1
Both Exocrine Pancreatic Insufficiency and Signs of Pancreatic Inflammation Are Prevalent in Children with Complicated Severe Acute Malnutrition: An Observational Study. ( 27178623 )
2016
2
Rapid maxillary expansion in a pediatric patient with exocrine pancreatic insufficiency. ( 26943081 )
2016
3
Exocrine Pancreatic Insufficiency. ( 26834230 )
2016
4
Evidence-based Guidelines for the Management of Exocrine Pancreatic Insufficiency After Pancreatic Surgery. ( 27045859 )
2016
5
Oral Supplementation with a Special Additive of Retinyl Palmitate and Alpha Tocopherol Reduces Growth Retardation in Young Pancreatic Duct Ligated Pigs Used as a Model for Children Suffering from Exocrine Pancreatic Insufficiency. ( 27690005 )
2016
6
Feline Exocrine Pancreatic Insufficiency: A Retrospective Study of 150 Cases. ( 27641602 )
2016
7
Safety and Efficacy of a Novel Microbial Lipase in Patients with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: A Randomized Controlled Clinical Trial. ( 27297209 )
2016
8
Applicability of a checklist for the diagnosis and treatment of severe exocrine pancreatic insufficiency. A survey on the management of pancreatic maldigestion in Italy. ( 27309260 )
2016
9
Atrophic Exocrine Pancreatic Insufficiency Associated with Anti-PD1 Therapy. ( 27864215 )
2016
10
Novel ciliate lipases for enzyme replacement during exocrine pancreatic insufficiency. ( 27518039 )
2016
11
Lipomatous pseudohypertrophy of pancreas with coexisting chronic calcific pancreatitis leading to malabsorption due to exocrine pancreatic insufficiency. ( 28050116 )
2016
12
Exocrine pancreatic insufficiency in a child with Netherton syndrome. ( 26986028 )
2016
13
Challenges and Updates in the Management of Exocrine Pancreatic Insufficiency. ( 26658035 )
2016
14
Romanian Guidelines on the diagnosis and treatment of exocrine pancreatic insufficiency. ( 25822444 )
2015
15
Exocrine pancreatic insufficiency, MRI of the pancreas and serum nutritional markers in patients with coeliac disease. ( 26253920 )
2015
16
Juvenile Diabetes Mellitus and Concurrent Exocrine Pancreatic Insufficiency in a Labrador Retriever: Long-Term Management. ( 26535463 )
2015
17
Exocrine pancreatic insufficiency is not a cause of abdominal complaints in patients with Fabry disease. ( 25835592 )
2015
18
Exocrine pancreatic insufficiency in diabetic patients: prevalence, mechanisms, and treatment. ( 25892991 )
2015
19
Diagnosis of Exocrine Pancreatic Insufficiency. ( 26077487 )
2015
20
Association of DLA-DQB1 alleles with exocrine pancreatic insufficiency in Pembroke Welsh Corgis. ( 26095904 )
2015
21
Exocrine Pancreatic Insufficiency after Roux-en-Y gastric bypass. ( 26965152 )
2015
22
Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus. ( 26495784 )
2015
23
Comparison of fecal elastase 1 for exocrine pancreatic insufficiency evaluation between ex-alcoholics and chronic pancreatitis patients. ( 25591157 )
2014
24
A piglet with surgically induced exocrine pancreatic insufficiency as an animal model of newborns to study fat digestion. ( 25348808 )
2014
25
Prevalence of exocrine pancreatic insufficiency in type 2 diabetes mellitus with poor glycemic control. ( 25278304 )
2014
26
Safety and efficacy of CreonAr Micro in children with exocrine pancreatic insufficiency due to cystic fibrosis. ( 25066363 )
2014
27
Case report of exocrine pancreatic insufficiency in two palliative care patients. ( 24699789 )
2014
28
Pancreatic enzyme replacement therapy in patients with exocrine pancreatic insufficiency due to chronic pancreatitis: a 1-year disease management study on symptom control and quality of life. ( 24717829 )
2014
29
Long-Term Experience With ZENPEP in Infants With Exocrine Pancreatic Insufficiency Associated With Cystic Fibrosis. ( 25050848 )
2014
30
Johanson-Blizzard syndrome: expanding the phenotype of exocrine pancreatic insufficiency. ( 25076350 )
2014
31
Exocrine pancreatic insufficiency and chronic pancreatitis in chronic alcoholic liver disease: coincidence or shared toxicity? ( 24713840 )
2014
32
Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian association for the study of the pancreas. ( 24307787 )
2013
33
Recovery from exocrine pancreatic insufficiency in a patient with fulminant type 1 diabetes. ( 23448767 )
2013
34
Manual ventilation therapy and aggressive potassium supplementation in the management of respiratory failure secondary to severe hypokalaemia in a cat with exocrine pancreatic insufficiency. ( 24065706 )
2013
35
CTLA-4 +49 and TNF-alpha-308 gene polymorphisms in celiac patients with exocrine pancreatic insufficiency. ( 24611333 )
2013
36
Low prevalence of exocrine pancreatic insufficiency in patients with diabetes mellitus. ( 23890131 )
2013
37
Exocrine pancreatic insufficiency following esophagectomy. ( 23199208 )
2013
38
Biallelic PDX1 (insulin promoter factor 1) mutations causing neonatal diabetes without exocrine pancreatic insufficiency. ( 23320570 )
2013
39
Early spontaneous recovery of exocrine pancreatic insufficiency in a 3-year-old child with Shwachman-Diamond syndrome. ( 24052373 )
2013
40
Screening and risk factors of exocrine pancreatic insufficiency in critically ill adult patients receiving enteral nutrition. ( 23924602 )
2013
41
Exocrine pancreatic insufficiency in the cat. ( 23148851 )
2012
42
Behavioral changes in response to feeding pancreatic-like enzymes to exocrine pancreatic insufficiency pigs. ( 23365403 )
2012
43
Hyperammonaemia due to cobalamin malabsorption in a cat with exocrine pancreatic insufficiency. ( 22907395 )
2012
44
The growing pancreatic duct ligated pig as a model for exocrine pancreatic insufficiency in children: investigations to achieve sufficient vitamin A and vitamin E supply. ( 23365367 )
2012
45
Exocrine pancreatic insufficiency in the dog: breed associations, nutritional considerations, and long-term outcome. ( 23148849 )
2012
46
Exocrine pancreatic insufficiency in the dog: historical background, diagnosis, and treatment. ( 23148848 )
2012
47
Current status of genetic studies of exocrine pancreatic insufficiency in dogs. ( 23148850 )
2012
48
Exocrine pancreatic insufficiency in dogs and cats: online support for veterinarians and owners. ( 23148852 )
2012
49
Prececal digestibility of various sources of starch in minipigs with or without experimentally induced exocrine pancreatic insufficiency. ( 23365290 )
2012
50
Introduction: exocrine pancreatic insufficiency and pancreatitis. ( 23148847 )
2012

Variations for Exocrine Pancreatic Insufficiency

Expression for Exocrine Pancreatic Insufficiency

Search GEO for disease gene expression data for Exocrine Pancreatic Insufficiency.

Pathways for Exocrine Pancreatic Insufficiency

Pathways related to Exocrine Pancreatic Insufficiency according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 11.46 CFTR PDX1 PTF1A
2 11.11 CCKAR CFTR PNLIP
3 9.47 CCK SCT

GO Terms for Exocrine Pancreatic Insufficiency

Biological processes related to Exocrine Pancreatic Insufficiency according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 generation of precursor metabolites and energy GO:0006091 9.26 COX4I2 PDX1
2 positive regulation of insulin secretion involved in cellular response to glucose stimulus GO:0035774 9.16 CFTR PDX1
3 pancreas development GO:0031016 8.96 PDX1 PTF1A
4 exocrine pancreas development GO:0031017 8.62 PDX1 PTF1A

Sources for Exocrine Pancreatic Insufficiency

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....